In this episode, Dr. John Christodouleas, Elekta’s Senior Vice President of Medical Affairs and Clinical Research, gives his take on scientific highlights from the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including promising evidence for MR-guided radiation therapy for prostate patients and the growing potential of low-dose radiation therapy for non-malignant conditions. He also addresses the ongoing debate around proton therapy and explains why he believes the future of radiation therapy is adaptive.

Tune in to hear why John thinks he has the best job in the world and who the newest member of the Medical Affairs team is.